High prognostic significance of residual disease after neoadjuvant chemotherapy: a retrospective study in 710 patients with operable breast cancer

By Abrial Sophie   Penault-Llorca Frédérique   Delva Rémi   Bougnoux Philippe   Leduc Bernard   Mouret-Reynier Marie-Ange   Mery-Mignard Dominique   Bleuse Jean-Pierre   Dauplat Jacques   Curé Hervé   Chollet Philippe  

Breast Cancer Research and Treatment, Vol. 94, Iss. 3, 2005-12 ,pp. : 255-263

Springer Publishing Company

Access to resources Recommend Favorite

Imaging Response and Residual Metastatic Axillary Lymph Node Disease after Neoadjuvant Chemotherapy for Primary Breast Cancer

By Hieken Tina   Boughey Judy   Jones Katie   Shah Sejal   Glazebrook Katrina  

Annals of Surgical Oncology, Vol. 20, Iss. 10, 2013-10 ,pp. : 3199-3204

Springer Publishing Company

Access to resources Recommend Favorite

Accuracy of MRI for estimating residual tumor size after neoadjuvant chemotherapy in locally advanced breast cancer: Relation to response patterns on MRI

By Kim Hyun Jung   Im Young-Hyuck   Han Boo-Kyung   Choi Nami   Lee Jeeyun   Kim Jung Han   Choi Yoon-La   Ahn Jin-Seok   Nam Seok-Jin   Park Young Suk   Choe Yeon Hyeon   Ko Young-Hyeh   Yang Jung-Hyun  

Acta Oncologica, Vol. 46, Iss. 7, 2007-01 ,pp. : 996-1003

Informa Healthcare

Access to resources Recommend Favorite

Breast conservation after neoadjuvant chemotherapy: the MD Anderson Cancer Center experience

By  

The Women's Oncology Review, Vol. 4, Iss. 3, 2004-09 ,pp. : 225-227

Informa Healthcare

Access to resources Recommend Favorite

Breast conservation after neoadjuvant chemotherapy: the MD Anderson Cancer Center experience

By  

The Women's Oncology Review, Vol. 4, Iss. 4, 2004-12 ,pp. : 311-312

Informa Healthcare

Access to resources Recommend Favorite